Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Chengcheng Fu

6PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Aug 18, 2025
Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and/or in main clone.

Hongying You, Weiqin Yao, Lingzhi Yan

|Jul 02, 2025
Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myeloma.

Yanlei Gong, Tingting Tao, Mo Zhou

|Feb 26, 2025
Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with De Novo Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial.

Xiang Zhang, Yue Han, Huiying Qiu

|Jan 12, 2023
Autologous stem cell transplantation in multiple myeloma patients with renal impairment.

Yingying Zhai, Lingzhi Yan, Song Jin

|Oct 14, 2022
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies.

Yifan Zhai, Qiuqiong Tang, Douglas D Fang

|Feb 03, 2022
Anti-CD19 and anti-BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myeloma.

Xiaolan Shi, Lingzhi Yan, Jingjing Shang

Pageof 1

Frequent Collaborators

2 joint publications

Lingzhi Yan

2 joint publications

Shengli Xue

1 joint publications

Xiaolan Shi

1 joint publications

Yifan Zhai

1 joint publications

Qiuqiong Tang

1 joint publications

Douglas D Fang

1 joint publications

Jing Deng

1 joint publications

Kaixiang Zhang

1 joint publications

Qixin Wang

1 joint publications

Yan Yin

Frequent Collaborators

2 joint publications

Lingzhi Yan

2 joint publications

Shengli Xue

1 joint publications

Xiaolan Shi

1 joint publications

Yifan Zhai

Top Related Videos

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on : Apr 15, 2022

4.3K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.1K
See more related videos

Top Related Videos

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence <em>in situ</em> Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on : Apr 15, 2022

4.3K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.1K
See more related videos